Last reviewed · How we verify
Torrent's Nebivolol Tablets
Torrent's Nebivolol Tablets is a Small molecule drug developed by Torrent Pharmaceuticals Limited. It is currently in Phase 1 development.
At a glance
| Generic name | Torrent's Nebivolol Tablets |
|---|---|
| Sponsor | Torrent Pharmaceuticals Limited |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet (PHASE1)
- Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Torrent's Nebivolol Tablets CI brief — competitive landscape report
- Torrent's Nebivolol Tablets updates RSS · CI watch RSS
- Torrent Pharmaceuticals Limited portfolio CI
Frequently asked questions about Torrent's Nebivolol Tablets
What is Torrent's Nebivolol Tablets?
Torrent's Nebivolol Tablets is a Small molecule drug developed by Torrent Pharmaceuticals Limited.
Who makes Torrent's Nebivolol Tablets?
Torrent's Nebivolol Tablets is developed by Torrent Pharmaceuticals Limited (see full Torrent Pharmaceuticals Limited pipeline at /company/torrent-pharmaceuticals-limited).
What development phase is Torrent's Nebivolol Tablets in?
Torrent's Nebivolol Tablets is in Phase 1.